| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
5 companies
Sato Vicki L is a Director at Vir Biotechnology, Inc. with holdings across 5 companies. Recent SEC Form 4 filings include 0 buys and 21 sells.
Estimated insider holdings value: $17.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 9, 2022 | VIR Vir Biotechnology, Inc. | Director | Sell | 14,541 | $20.62 | $299,835.42 | -1.0% | +45.8% | +17.6% | |
| Apr 28, 2022 | VIR Vir Biotechnology, Inc. | Director | Sell | 17,915 | $20.90 | $374,423.60 | -0.6% | +37.1% | +16.4% | |
| Jan 18, 2022 | VIR Vir Biotechnology, Inc. | Director | Sell | 15,173 | $37.39 | $567,385.23 | -1.0% | -35.6% | -26.7% | |
| Dec 20, 2021 | VIR Vir Biotechnology, Inc. | Director | Sell | 15,174 | $54.53 | $827,484.62 | -0.2% | -50.5% | -50.1% | |
| Nov 26, 2021 | VIR Vir Biotechnology, Inc. | Director | Sell | 15,174 | $36.80 | $558,403.20 | -1.0% | -21.6% | -24.4% | |
| Nov 10, 2021 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,666 | $52.81 | $87,982.94 | -0.7% | -30.8% | -41.6% | |
| Nov 1, 2021 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,666 | $50.05 | $83,383.30 | -1.3% | -31.6% | -42.1% | |
| Oct 19, 2021 | VIR Vir Biotechnology, Inc. | Director | Sell | 15,174 | $39.56 | $600,313.80 | -0.5% | -11.3% | -49.1% | |
| Sep 17, 2021 | VIR Vir Biotechnology, Inc. | Director | Sell | 15,174 | $52.48 | $796,301.19 | -0.5% | -0.9% | -63.3% | |
| Sep 15, 2021 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,666 | $53.40 | $88,969.48 | -0.3% | -14.1% | -40.9% |